Neoadjuvant chemotherapy for ovarian cancer: clarifying the confusion

Comment

Robert C Wallach. Oncology (Williston Park). 2008.

. 2008 Nov 30;22(13):1456; author reply 1456-7.

No abstract available

Comment on

What is the role of neoadjuvant chemotherapy in the management of ovarian cancer?
Schwartz PE. Schwartz PE. Oncology (Williston Park). 2008 Sep;22(10):1118-25; discussion 1130, 1132, 1134. Oncology (Williston Park). 2008. PMID: 18935925 Review.

[Neoadjuvant chemotherapy in the treatment of ovarian cancer].
Lehoczky O. Lehoczky O. Orv Hetil. 2005 Sep 18;146(38):1951-5. Orv Hetil. 2005. PMID: 16238247 Review. Hungarian.
Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer.
Markman M. Markman M. Gynecol Oncol. 2007 Jul;106(1):273-4; author reply 274-5. doi: 10.1016/j.ygyno.2007.03.013. Epub 2007 Apr 30. Gynecol Oncol. 2007. PMID: 17467780 No abstract available.
Adjuvant chemotherapy improves survival after resection of stage 1 ovarian cancer.
Kitchener HC. Kitchener HC. Cancer Treat Rev. 2005 Jun;31(4):323-7. doi: 10.1016/j.ctrv.2005.04.003. Cancer Treat Rev. 2005. PMID: 15905036 Review. No abstract available.
LTE-commenting on "Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer" (90: 163-9).
Eisenkop SM. Eisenkop SM. Gynecol Oncol. 2004 Mar;92(3):1017-8; author reply 1018-9. doi: 10.1016/j.ygyno.2003.11.050. Gynecol Oncol. 2004. PMID: 14984983 No abstract available.
Current aspects of adjuvant therapy of early stage ovarian cancer.
McGuire WP. McGuire WP. Zentralbl Gynakol. 1998;120(3):93-7. Zentralbl Gynakol. 1998. PMID: 9556898 Review.